MX9703975A - Nueva formulacion antitrombotica, proceso para su fabricacion y uso de la misma. - Google Patents

Nueva formulacion antitrombotica, proceso para su fabricacion y uso de la misma.

Info

Publication number
MX9703975A
MX9703975A MX9703975A MX9703975A MX9703975A MX 9703975 A MX9703975 A MX 9703975A MX 9703975 A MX9703975 A MX 9703975A MX 9703975 A MX9703975 A MX 9703975A MX 9703975 A MX9703975 A MX 9703975A
Authority
MX
Mexico
Prior art keywords
formulation
manufacturing
new antithrombotic
thromboembolism
new
Prior art date
Application number
MX9703975A
Other languages
English (en)
Other versions
MXPA97003975A (es
Inventor
Jan-Erik Lofroth
Anna Lena Ungell
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of MX9703975A publication Critical patent/MX9703975A/es
Publication of MXPA97003975A publication Critical patent/MXPA97003975A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Se proporciona una nueva formulacion farmacéutica que comprende el inhibidor de trombina HOOC-CH2-(R)-Cgl-Aze-Pab en combinacion con uno o más agentes mejoradores de absorcion, un proceso para la preparacion de tal formulacion farmacéutica, el uso de tal formulacion en el tratamiento de tromboembolia así como para tratar a un paciente en necesidad de tratamiento antitrombotico y tromboembolia mediante la utilizacion de la formulacion.
MXPA/A/1997/003975A 1994-12-02 1997-05-29 Nueva formulacion antitrombotica, proceso para su fabricacion y uso de la misma MXPA97003975A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9404196A SE9404196D0 (sv) 1994-12-02 1994-12-02 New antithrombotic formulation
SE9404196-9 1994-12-02
PCT/SE1995/001425 WO1996016671A1 (en) 1994-12-02 1995-11-29 New antithrombotic formulation, process for its manufacturing, and use thereof

Publications (2)

Publication Number Publication Date
MX9703975A true MX9703975A (es) 1997-09-30
MXPA97003975A MXPA97003975A (es) 1998-07-03

Family

ID=

Also Published As

Publication number Publication date
NO972475L (no) 1997-05-30
PT799052E (pt) 2002-05-31
NZ297118A (en) 1998-12-23
HUT77655A (hu) 1998-07-28
EP0799052A1 (en) 1997-10-08
EP0799052B1 (en) 2001-11-14
ATE208628T1 (de) 2001-11-15
IL116153A0 (en) 1996-01-31
BR9509853A (pt) 1997-12-30
WO1996016671A1 (en) 1996-06-06
AU4191596A (en) 1996-06-19
FI972332A0 (fi) 1997-06-02
ZA9510242B (en) 1996-06-03
DE69523943D1 (de) 2001-12-20
TR199501517A2 (tr) 1996-07-21
HU216631B (hu) 1999-07-28
IS4483A (is) 1997-05-16
AR002254A1 (es) 1998-03-11
JPH10513438A (ja) 1998-12-22
DK0799052T3 (da) 2002-02-25
SE9404196D0 (sv) 1994-12-02
NO972475D0 (no) 1997-05-30
SK61797A3 (en) 1998-03-04
IL116153A (en) 1999-11-30
FI972332A (fi) 1997-06-02
PL320692A1 (en) 1997-10-27
EE03338B1 (et) 2001-02-15
ES2168395T3 (es) 2002-06-16
CA2206459A1 (en) 1996-06-06
CN1168635A (zh) 1997-12-24
US5795896A (en) 1998-08-18
AU689994B2 (en) 1998-04-09
DE69523943T2 (de) 2002-06-27
CZ147097A3 (cs) 1998-02-18

Similar Documents

Publication Publication Date Title
SE9404196D0 (sv) New antithrombotic formulation
UA32429C2 (uk) Засіб для лікування нетримання сечі
MX9700538A (es) Uso de droloxifeno y sus sales farmaceuticamente aceptables en la preparacion de remedios para las enfermedades cardiovasculares.
MY113059A (en) Controlled-release dosage forms of azithromycin
MX9704030A (es) 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
GR3019514T3 (en) Pharmaceutical preparation for the treatment of prolonged coagulation time
MY138883A (en) Use of asiatic acid for treatment of cencer
GB9305718D0 (en) Medicaments
AU6857887A (en) Therapeutic agent
KR950700726A (ko) 치료 또는 진단용 조성물, 그 제조방법 및 용도(composition for therapeutic or diagnostic use, process for its preparation and its use)
BG101126A (en) The use of muramylpeptide compounds
HU9201799D0 (en) New 2-amino-5-ciano-1,4-dihydropiridine-derivatives, process for their use and their use as medicaments
DE3462688D1 (en) 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases
SE9602145D0 (sv) New improved formulation for treatment of thromboembolism
ES2190581T3 (es) 2-aminotetralina opticamente activa, procedimiento para su preparacion y composiciones farmaceuticas que la contienen, activa en la prevencion y tratamiento de shock septico.
EP0458537A3 (en) Therapeutic compound for the treatment of bronchitis
RU96119673A (ru) Способ лечения болевого синдрома
PT1313500E (pt) Associacoes de dalfopristina/quinupristina com o cefpirome
NO984190L (no) FremgangsmÕte for behandling av insomnia
UA8280A (uk) Спосіб лікування псоріазу
AU2001248922A1 (en) Method and cleaning fluid for use in well cleaning and subsequent treatment of the used cleaning solution, as well as use of a particular fluid mixture
EA199800698A1 (ru) Способ лечения и фармацевтическая композиция
UA36485A (uk) Спосіб лікування генералізованого пародонтиту
UA33439A (uk) Спосіб інтенсивного лікування шизофренії
UA15180A (uk) Спосіб коhсервативhого лікуваhhя геhералізоваhого пародоhтиту

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees